Discontinued — last reported Q4 '25
Johnson & Johnson PP&E Sale Proceeds increased by 43.4% to $76.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 52.0%, from $50.00M to $76.00M.
An increase provides a one-time cash boost and may indicate a shift in strategy or the decommissioning of obsolete infrastructure.
The cash inflows received from the disposal or sale of property, plant, and equipment. This includes the liquidation of...
Analyzed alongside capital expenditures to determine the net investment in physical footprint.
cf_proceeds_from_sale_of_ppe| Q2 '21 | Q2 '22 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $603.00M | $248.00M | $40.00M | $210.00M | $363.00M | $50.00M | $52.00M | $279.00M | $53.00M | $76.00M |
| QoQ Change | — | -58.9% | -83.9% | +425.0% | +72.9% | -86.2% | +4.0% | +436.5% | -81.0% | +43.4% |
| YoY Change | — | -58.9% | -83.9% | — | +807.5% | — | — | +32.9% | -85.4% | +52.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.